2018
DOI: 10.15789/1563-0625-2018-2-151-162
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Innate Immunity Factors in Tumorigenesis Process

Abstract: Резюме. Одной из важнейших теорий канцерогенеза является теория о полиэтиологичности опухолеобразования. Большое место в этой теории отводится роли воспалительного компонента, который реализуется посредством факторов врожденного иммунитета.К факторам врожденного иммунитета, участвующим в опухолеобразовании, относятся TLRs, хемокины и их рецепторы. Активация TLRs может приводить как к снижению прогрессии онкологического процесса, так и, наоборот, к усилению. Известно, что TLR3, TLR5, TLR7, TLR9 обладают наиболь… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 39 publications
0
1
0
Order By: Relevance
“…TLR4 has a tumor-promoting effect [56]; however, monophosphoryl lipid A, a TLR4 agonist, enhances the adaptive immune response by promoting Th1 cell differentiation and increasing IFN-γ expression levels [57]. TLR5 and TLR7 have significant anti-tumor effects through dendritic cell-mediated cytotoxic T cells activation and regulatory T cell (Treg) inhibition [58]. In a therapeutic cancer vaccine model, flagellin was shown to improve the response of tumor-specific CD8 + T cells after TLR5 stimulation [59].…”
Section: Discussionmentioning
confidence: 99%
“…TLR4 has a tumor-promoting effect [56]; however, monophosphoryl lipid A, a TLR4 agonist, enhances the adaptive immune response by promoting Th1 cell differentiation and increasing IFN-γ expression levels [57]. TLR5 and TLR7 have significant anti-tumor effects through dendritic cell-mediated cytotoxic T cells activation and regulatory T cell (Treg) inhibition [58]. In a therapeutic cancer vaccine model, flagellin was shown to improve the response of tumor-specific CD8 + T cells after TLR5 stimulation [59].…”
Section: Discussionmentioning
confidence: 99%